7 Recruiting Pancreatic Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for pancreatic cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Pancreatic Cancer studiesPhase 1 / Phase 2 Studies for Pancreatic Cancer
🔵 Active, Not Recruiting Phase1 / Phase2
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
📍 Northwell Health / R.J. Zuckerberg Cancer Center — New Hyde Park, New York
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
📍 California Research Institute — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
📍 Tampa General Hospital — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
📍 The University of Kansas Cancer Center, Westwood Campus — Kansas City, Kansas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔